Report Materials
Baron Drug Company received improper payments of at least $79,000 from New Jersey, which the Centers for Medicare & Medicaid Services reimbursed under the "Reimbursement of State Costs for Provision of Part D Drug" Medicare demonstration project.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.